| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/04/2007 | CN1307909C Technological process for preparing beverage, oral liquor, granule, and antitoxic tablet from fern root |
| 04/03/2007 | US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 04/03/2007 | US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199136 Antiinflammatory agents, neutrophil elastase inhibitors; chronic obstructive pulmonary diseases |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | CA2425539C Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition |
| 04/03/2007 | CA2289570C 9-azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/03/2007 | CA2272343C Pharmaceutical compositions containing 3-iodo-1,2-propanediol having mucolytic activity |
| 04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
| 04/03/2007 | CA2180660C Novel piperidine derivatives with paf antagonist activity |
| 03/29/2007 | WO2007035158A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 03/29/2007 | WO2007035157A1 Alkylnitrile quinolines, as nk-3 receptor ligands |
| 03/29/2007 | WO2007035156A1 N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands |
| 03/29/2007 | WO2007035154A1 Novel n-pyrazinil-phenylsulfonamide derivatives as chemokine receptor modulators for use in the treatment of asthma |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |
| 03/29/2007 | WO2007034881A1 Novel adenine compound |
| 03/29/2007 | WO2007034817A1 Novel adenine compound |
| 03/29/2007 | WO2006131737A3 Method and composition for treating inflammatory disorders |
| 03/29/2007 | WO2006128142A3 Inhibitors of cytosolic phospholipase a2 |
| 03/29/2007 | US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 03/29/2007 | US20070072291 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070071824 Treatment of mucositis using N-acetylcysteine |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria |
| 03/29/2007 | US20070071689 Advantageous combination for inhalation of nacystelyn and bronchodilators |
| 03/29/2007 | US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 03/29/2007 | DE102005017923A1 Reizlinderndes Hustenmittel Reizlinderndes cough medicine |
| 03/29/2007 | DE102005017326A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 03/29/2007 | CA2621062A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1767216A1 Drug having regulatory cell ligand contained in liposome |
| 03/28/2007 | EP1767198A1 Regulator of physiological function of ghrelin and use thereof |
| 03/28/2007 | EP1767195A2 Stable spray-dried protein formulations |
| 03/28/2007 | EP1765809A1 Xanthine derivatives useful as muscarinic receptor antagonists |
| 03/28/2007 | EP1765768A1 Substituted acids for the treatment of respiratory diseases |
| 03/28/2007 | EP1765405A1 Combinations comprising antimuscarinic agents and corticosteroids |
| 03/28/2007 | EP1765404A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 03/28/2007 | EP1765401A2 Antibodies against human interleukin-13 and uses therefor |
| 03/28/2007 | EP1765355A1 Benzoxazine for treating respiratory tract diseases |
| 03/28/2007 | EP1765349A1 Opioids for the treatment of the chronic obstructive pulmonary disease (copd) |
| 03/28/2007 | EP1765339A2 Muscarinic acetylcholine receptor antagonists |
| 03/28/2007 | EP1765331A1 Methods and compositions for the treatment of pulmonary diseases |
| 03/28/2007 | EP1765313A2 Compounds for immunopotentiation |
| 03/28/2007 | EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 03/28/2007 | EP1228071B1 Pharmaceutically active isoindoline derivatives |
| 03/28/2007 | CN1938274A Novel piperidines as chemokine modulators (CCR) |
| 03/28/2007 | CN1938019A Protein kinase C inhibitors for the treatment of autoimmune diseases and of transplant rejection |
| 03/28/2007 | CN1938011A Pharmaceutical product containing tranilast |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935250A Baoning pinellia tuber granules for relieving cough and sputum, and regulating stomach and stopping vomitting, and its production method |
| 03/28/2007 | CN1935240A Quality control method for Chinese medicine composition preparation for treating children's cold |
| 03/28/2007 | CN1935237A Emplastrum for injury, bone, flatulence relieving and inflammation and its use |
| 03/28/2007 | CN1935213A Use of total saponinof sapindusmukeossi for preparing clinical medicine |
| 03/28/2007 | CN1935205A Animal medicament with clearing lung and eliminating phlegm, and regulating stomach, and its preparing method |
| 03/28/2007 | CN1935199A Quality control method for Chinese medicine compound preparation |
| 03/28/2007 | CN1935165A Moringaceae tablet and its producing method |
| 03/28/2007 | CN1935158A Pediatric paracetamol artifical low-bezoar and chlorphenzmine maleategel preparation and its preparing method |
| 03/28/2007 | CN1935142A Slow-release capsule using noinclude, loratadine and pseudoephedrinesulfate as effective component, and its preparing method |
| 03/28/2007 | CN1935132A Oral medicinal composition containing fudosteine |
| 03/28/2007 | CN1307176C Novel alkoxypyridine-derivatives |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307157C Novel compounds |
| 03/28/2007 | CN1307150C Hydroxy tetrahydro-naphthalenylurea derivatives |
| 03/28/2007 | CN1306952C Chinese traditional medicine for treating chronic pharyngolaryngitis and its preparing process |
| 03/28/2007 | CN1306946C Snuffle dredging capsule |
| 03/28/2007 | CN1306943C Chinese herbal medicine for treating cynanche |
| 03/28/2007 | CN1306941C Skin preparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 03/28/2007 | CN1306928C Method for preparing Chinese traditional medicine for treating laryngopharyngeal paresthesia |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196098 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2134966C Antibodies with specificity for multiple adhesion molecules |
| 03/22/2007 | WO2007032720A1 Method and means of preventing and treating sleep disordered breathing |
| 03/22/2007 | WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032445A1 Protein kinase inhibitors |
| 03/22/2007 | WO2007032376A1 SECRETORY IgA AND IgG ANTIBODIES-INDUCING AGENT |
| 03/22/2007 | WO2007031977A2 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 03/22/2007 | WO2007031838A1 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |